Pathstone Family Office’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $290K | Buy |
+3,275
| New | +$290K | ﹤0.01% | 1326 |
|
|
2021
Q1 | – | Sell |
-71
| Closed | -$6K | – | 728 |
|
|
2020
Q4 | $6K | Sell |
71
-150
| -68% | -$12.7K | ﹤0.01% | 918 |
|
|
2020
Q3 | $16K | Sell |
221
-2,850
| -93% | -$206K | ﹤0.01% | 520 |
|
|
2020
Q2 | $379K | Hold |
3,071
| – | – | 0.04% | 122 |
|
|
2020
Q1 | $260K | Buy |
+3,071
| New | +$260K | 0.04% | 145 |
|
|
2017
Q2 | – | Sell |
-7
| Closed | -$1K | – | 413 |
|
|
2017
Q1 | $1K | Buy |
+7
| New | +$1K | ﹤0.01% | 434 |
|